120. An open-label comparative trial of SUBA-itraconazole (SUBA) versus conventional itraconazole (c-itra) for treatment of proven and probable endemic mycoses (MSG-15): a pharmacokinetic (PK) and adverse Event (AE) analysis
120. SUBA-伊曲康唑 (SUBA) 与传统伊曲康唑 (c-itra) 治疗已确诊和疑似地方性真菌病的开放标签比较试验 (MSG-15)：药代动力学 (PK) 和不良事件 (AE) 分析
期刊:Brazilian Journal of Microbiology
影响因子:1.9
doi:10.1007/s42770-020-00387-x
Toriello, Conchita; Brunner-Mendoza, Carolina; Ruiz-Baca, Estela; Duarte-Escalante, Esperanza; Pérez-Mejía, Amelia; Del Rocío Reyes-Montes, María; Pappas, Peter G; Spec, Andrej; Miceli, Marisa; McGwin, Gerald; McMullen, Rachel; Thompson III, George R R
